Reading time: 4 minutes Keighley Reisenauer One of the “hot button” topics right now in the cancer therapeutics industry is precision medicine. This is a practice whereby a tumor’s genetics, immune landscape, and biomarkers are compiled and evaluated holistically in order to more accurately make treatment decisions. Breast cancer especially has benefited from the targeted... Continue Reading →